Samjoo IA - Search Results

1

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. J Comp Eff Res. 2021 Dec;10(17):1267-1269. doi: 10.2217/cer-2021-0203. Epub 2021 Oct 5. J Comp Eff Res. 2021. PMID: 34608814 Free article. No abstract available.

2

O2-sensitive K+ channels in immortalised rat chromaffin-cell-derived MAH cells.

Fearon IM, Thompson RJ, Samjoo I, Vollmer C, Doering LC, Nurse CA. Fearon IM, et al. J Physiol. 2002 Dec 15;545(3):807-18. doi: 10.1113/jphysiol.2002.028415. J Physiol. 2002. PMID: 12482887 Free PMC article.

3

Adiposity and immune-muscle crosstalk in South Asians &Europeans: A cross-sectional study.

Samaan MC, Anand SS, Sharma AM, Bonner A, Beyene J, Samjoo I, Tarnopolsky MA. Samaan MC, et al. Sci Rep. 2015 Oct 12;5:14521. doi: 10.1038/srep14521. Sci Rep. 2015. PMID: 26455502 Free PMC article.

4

Letter to the editor concerning the article: "An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".

Salvo EM, Samjoo IA, Tran D, Cameron C. Salvo EM, et al. Among authors: samjoo ia. Expert Opin Pharmacother. 2019 Aug;20(12):1527-1528. doi: 10.1080/14656566.2019.1620983. Epub 2019 May 24. Expert Opin Pharmacother. 2019. PMID: 31124724 No abstract available.

5

The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.

Samjoo IA, Salvo EM, Tran D, Amass L, Stewart M, Cameron C. Samjoo IA, et al. Curr Med Res Opin. 2020 May;36(5):799-808. doi: 10.1080/03007995.2020.1725742. Epub 2020 Feb 17. Curr Med Res Opin. 2020. PMID: 32011182

6

The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.

Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Dahlke F, Adlard N. Samjoo IA, et al. Curr Med Res Opin. 2020 Jul;36(7):1145-1156. doi: 10.1080/03007995.2020.1747998. Epub 2020 Apr 14. Curr Med Res Opin. 2020. PMID: 32216597

7

Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.

Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Rouyrre N, Dahlke F, Adlard N. Samjoo IA, et al. Curr Med Res Opin. 2020 Jul;36(7):1157-1166. doi: 10.1080/03007995.2020.1747999. Epub 2020 Apr 14. Curr Med Res Opin. 2020. PMID: 32220214

8

Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. J Comp Eff Res. 2020 Dec;9(18):1255-1274. doi: 10.2217/cer-2020-0122. Epub 2020 Oct 22. J Comp Eff Res. 2020. PMID: 33090003 Free article.

9

Efficacy classification of modern therapies in multiple sclerosis.

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. J Comp Eff Res. 2021 Apr;10(6):495-507. doi: 10.2217/cer-2020-0267. Epub 2021 Feb 23. J Comp Eff Res. 2021. PMID: 33620251 Free article.

10

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.

Salvo EM, Ramirez AO, Cueto J, Law EH, Situ A, Cameron C, Samjoo IA. Salvo EM, et al. Among authors: samjoo ia. Breast. 2021 Jun;57:5-17. doi: 10.1016/j.breast.2021.02.009. Epub 2021 Feb 20. Breast. 2021. PMID: 33677313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters